Pediatric Oncology
The Strategic Case for Investing in Pediatric Oncology, Beyond Altruism
Emilee Kudla
Pharma's Almanac
PAO-08-25-NI-04Aug 05, 2025
Pediatric Oncology
The "Therapeutic Winter" and Why Urgent Innovation in Pediatric Oncology Is Being Left Behind
Emilee Kudla
Pharma's Almanac
PAO-08-25-NI-03Aug 05, 2025
Neurodegenerative
Leriglitazone Marketing Authorization Application Submitted For Treatment of Cerebral Adrenoleukodystrophy Has Been Validated
Minoryx
PR-07-25-NI-2Jul 23, 2025
TPD
Five Small Biotechs to Watch: June 2025
David Alvaro, Ph.D.
Pharma's Almanac
PAO-06-25-NI-04Jun 05, 2025
Biotechs
Five Small Biotechs to Watch: May 2025
David Alvaro, Ph.D.
Pharma's Almanac
PAO-05-25-NI-01May 01, 2025
Small Biotechs
Five Small Biotechs to Watch: March 2025
David Alvaro, Ph.D.
Pharma's Almanac
PAO-02-25-NI-06Feb 28, 2025
Biotechs
Five Small Biotechs to Watch: February 2025
David Alvaro, Ph.D.
Pharma's Almanac
PAO-02-25-NI-01Feb 03, 2025
Announcement
CellFE® Announces Strategic Placements with Leading Pharma and Biotech Companies
CellFE
PR-12-24-NI-143Dec 19, 2024
Regulatory
Adapting Medical Information Services to Japan’s Distinct Needs
Jim Leaver, Ph.D.
PrimeVigilance
PAO-11-24-CL-03Nov 22, 2024
Gene Silencing
‘Gene silencing’ therapies market set to boom, says leading biotech
SynaptixBio
PR-11-24-NI-115Nov 20, 2024
biotechnology
Atlas Venture targets $450M for 14th biotech fund, the same size as its 2022 raise
Atlas Venture
PR-11-24-NI-111Nov 18, 2024
Bioscience
Neurocrine Biosciences Presents Breadth of Data Over Time Following Treatment With INGREZZA Capsules
Neurocrine Biosciences
PR-10-24-NI-71Nov 04, 2024
Nice Insight Reports
Biotech Funding Ups and Downs
April Stanley, MS MBA
Nice Insight
PAO-04-24-NI-01Apr 02, 2024
Alloy Therapeutics and Wheeler Bio Announce Preferred Service Offering for Alloy Partners to Accelerate the Translation from Discovery to CMC
Wheeler Bio
PR-M11-23-01Nov 08, 2023
Wheeler Bio Announces Grand Opening of Biomanufacturing Facility
Wheeler Bio
PR-M10-23-01Oct 05, 2023
Immuno-Oncology
Targeted Immune System Activation: A Paradigm Shift in Immuno-oncology
Dan Passeri, M.Sc., J.D.
Cue Biopharma
PAO-12-022-CL-01Jan 04, 2023
Synthetic Biology
Synthetic Biology: A Potential Game-Changer for the Biopharma Industry
Cynthia A. Challener, Ph.D.; David Alvaro, Ph.D.
Pharma's Almanac
PAO-12-022-NI-01Dec 23, 2022
Digital Therapeutics
Digital Therapeutics and the Song of the Future of Healthcare
Chris E. Rivera; Xavier A. Figueroa
EMulate Therapeutics
PAO-12-022-CL-02Dec 20, 2022
Hemostatic
Stopping Bleeds and Saving Lives
Joe Landolina
Cresilon
PAO-11-022-CL-09Nov 16, 2022
Plant-Inspired Drug Discovery
Unlocking the Therapeutic Potential of Plant-Inspired Minimum Essential Mixtures
Andrea Small-Howard, Ph.D.
Gb Sciences, Inc.
PAO-08-022-CL-01Sep 06, 2022